Divergent States

In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run.

Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FD...

Dr. Bronner’s Cosmic Engagement Officer David Bronner joins Divergent States for a candid, nuts-and-bolts conversation about building an “All One” company culture, pushing for psychedelic policy reform, and rewiring global supply chains to be fair, transparent, and regenerative. We trace the lineage from Rainbow Gatherings to Burning Man, from hemp activism to MAPS, and from commodity brokers to farmer-first vertical integration. C...

Psychedelics are no longer the fringe—they’re reshaping medicine, culture, and consciousness itself.

In this episode of Divergent States, 3L1T3 and Bryan sit down with Joe Moore, co-founder and CEO of Psychedelics Today, to explore the messy evolution of the movement: from the chaotic 1960s to today’s corporate clinics and grassroots revival.

They trace Psychedelics Today’s origins, dive into the Vital training program, and discuss w...

Comedian, musician, and improvisational genius Reggie Watts joins Divergent States for an unfiltered deep dive into psychedelics, creativity, and consciousness. From jamming on LSD and mushrooms to experimenting with dissociatives and even the Apple Vision Pro, Reggie opens up about how altered states shape his art, comedy, music, and worldview.

We cover:

• Psychedelics in creative flow and improvisation
• Dissociatives as “drug-induc...

History shows politics can make or break psychedelic medicine, will we repeat the 1960s backlash, or finally move forward? 

In this episode of Divergent States, we explore the uneasy intersection of psychedelics and politics. MDMA remains a Schedule I drug—classified as dangerous with no medical use—while at the same time advancing through FDA Phase III trials. This contradiction highlights the limbo psychedelics face today: crimina...

In this episode of Divergent States, we sit down with Kabir Nath, CEO of Compass Pathways, and Dr. Steve Levine, Chief Patient Officer, to talk about the future of psychedelic medicine. From FDA approval and insurance coverage to patient access, cultural safety, and patents, we dig into whether Compass is truly disrupting the pharma model or just reinventing it.

We also share a major community update: the official Divergent States D...

In this episode of Divergent States, host 3L1T3 and co-host Bryan sit down with Paul F. Austin, founder of The Third Wave and the Psychedelic Coaching Institute.

We dive deep into microdosing psychedelics, intentional use for peak performance, and the rise of psychedelic coaching as a professional path. Paul shares insights from his book Mastering Microdosing, his vision for conscious entrepreneurship, and how psychedelics are resha...

Amber Capone, co-founder and CEO of Veterans Exploring Treatment Solutions (VETS), shares the powerful story of how psychedelic therapy - starting with Ibogaine - helped her husband, Navy SEAL Marcus Capone, recover from PTSD and TBI when traditional care failed.

We dive into the science and controversy behind Ibogaine, the limits of VA mental health care, and how VETS is paving the way for safe access to psychedelics like MDMA, psi...

What happens when the most hunted man in psychedelic history walks free and joins us for a conversation?

In this deeply reflective episode of Divergent States, I sit down with William Leonard Pickard: chemist, philosopher, author of The Rose of Paracelsus, and the man once called the “Acid King.” After decades behind bars, Pickard returns with revelations about time, memory, suffering, redemption, and the spiritual cost of psychedel...

In this episode, 3L1T3 sits down with Dr. Anne Wagner, clinical psychologist and founder of Remedy, whose research pushes MDMA therapy beyond the individual — into the space between two people. We explore what happens when couples facing PTSD enter treatment together, why trauma rarely belongs to just one partner, and whether psychedelic medicine can transform relational patterns where traditional therapy fails.

We also examine the ...

A former U.S. Senator says the federal government is preparing to fast-track psychedelic medicines, especially for veterans with TBI, PTSD, addiction, and treatment-resistant depression.

In this conversation, Kyrsten Sinema explains why the current administration is unusually aligned behind plant-based therapies, how Ibogaine and MDMA could move through the FDA faster than expected, and why small researchers, not Big Pharma, may end...

This week, we sit down with Kevin Cranford, Communications Officer at MAPS (Multidisciplinary Association for Psychedelic Studies), to talk about the upcoming Psychedelic Science 2025 conference — what’s new, what’s different, and why it’s shaping up to be more than just another gathering. From navigating hype vs. science to MAPS’ comms strategy, Kevin shares how the org is threading the needle between community storytelling, rigor...

In this powerful new episode of Divergent States, your hosts 3L1T3 and Bryan sit down with Tom Feegel—CEO and Co-Founder of Beond, a pioneering Ibogaine clinic based in Mexico, to discuss the unfiltered realities of healing, addiction recovery, and the evolving landscape of psychedelic-assisted therapy.

Tom brings two decades of sobriety, a past life in global brand marketing, and deep experience navigating both the light ...

What does it mean to be a responsible psychonaut?

In this episode of Divergent States, we sit down again with Valerie Beltran, licensed therapist, harm reduction expert, and educator with the Zendo Project, to unpack 7 core principles for navigating psychedelic states with intention, safety, and compassion.

We break down everything from testing your stash to dismantling your ego, and talk about how these powerful tools can help us gr...

In this episode of Divergent States, we sit down with Alli Schaper, CEO of Supermush and co-founder of the Microdosing Collective, to explore the evolving world of functional and psychedelic mushrooms. Alli shares her journey into microdosing advocacy, the challenges of navigating the gray market for psychedelics, and the urgent push for policy reform to ensure safe, legal access.

We dive into the science behind microdosing, its pro...

In this deeply personal and eye-opening episode, we sit down with filmmaker JR Sawyers, the mind behind the indie psychedelic drama A Trip Elsewhere. What begins as a conversation about a film turns into a powerful exploration of transformation, healing, and consciousness.

JR opens up about the psychedelic retreat that changed his life, the emotional weight of isolation during the pandemic, and how he turned those experiences into c...

In this powerful episode of Divergent States, we’re joined by Valerie Beltran and Chelsea Rose-Pires of the Zendo Project- an organization redefining harm reduction and compassionate care at festivals, events, and beyond.

We explore how the Zendo Project began as a MAPS initiative and evolved into its own nonprofit dedicated to supporting people through difficult psychedelic experiences and emotional crises, not with judgment or cli...

In this episode of Divergent States, we talk with Dylalien: psychedelic DJ, producer, schoolteacher, and longtime organizer of Goa Gil’s legendary all-night, open-air ritual dance parties. You’ve heard his music on this podcast, but in this conversation, we go deep on what it means to create and participate in psychedelic music culture at its most raw, weird, and transformative.

Together, we explore:

• The life and legacy of Goa Gi...

In this profound episode of Divergent States, we welcome Wendy Tucker, daughter of Ann Shulgin and stepdaughter of the legendary Sasha Shulgin, the "Godfather of Ecstasy." Wendy shares intimate stories of growing up at the iconic Shulgin Farm, working alongside Sasha in his lab, and her mission to preserve their legacy through the Shulgin Foundation.

Key Topics Covered:

• Sasha’s Lab & Humble Genius: Wendy recounts be...